Ignite Creation Date:
2024-05-06 @ 8:49 AM
Last Modification Date:
2024-10-26 @ 12:05 PM
Study NCT ID:
NCT02827565
Status:
COMPLETED
Last Update Posted:
2018-08-08
First Post:
2016-07-06
Brief Title:
Technical Optimization of Detection of KRAS BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer
Sponsor:
Institut de Cancérologie de Lorraine
Organization:
Institut de Cancérologie de Lorraine
Study Overview
Official Title:
Prospective Study of Technical Optimization of the Detection of KRAS Mutations BRAF and NRAS by Next Generation Sequencing on Tumor DNA Circulating in Metastatic Colorectal Cancer
Status:
COMPLETED
Status Verified Date:
2018-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CircuLOR-1
Brief Summary:
The objective of this study is to optimize the search by next-generation sequencing NGS mutations in the KRAS BRAF and NRAS on circulating tumor DNA and compare the genetic profiles obtained with those from tumors embedded in paraffin
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None